CASC2 and neoplasm: The lncRNA CASC2 (cancer susceptibility candidate 2) was found to act as a tumour suppressor in Pca through sponging of miR-183-5p, derepressing the miR-183-5p direct target SPRY2 (Sprouty2) [114].